Reports for CHEPLAPHARM ARZNEIMITTEL GMBH

Company Name

CHEPLAPHARM ARZNEIMITTEL GMBH

Totals

Shortage reports

38
Actual shortage: 4 (11%)
Anticipated shortage: 0 (0%)
Avoided shortage: 1 (3%)
Resolved: 33 (87%)

Discontinuation Reports

4
To be discontinued: 0 (0%)
Discontinued: 4 (100%)
Reversed: 0 (0%)

Late reports

4 (10%)

Overdue reports

1 (25%)
Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
SUPREFACT 1MG SOLUTION Resolved 2017-05-12 2017-07-06 10149
SUPREFACT 1MG SOLUTION Resolved 2020-01-30 2020-02-19 104798
SUPREFACT 1MG SOLUTION Resolved 2021-12-13 2022-02-15 151046
SUPREFACT 1MG SOLUTION Resolved 2022-05-06 2022-05-25 160170
SUPREFACT 1MG SOLUTION Resolved 2022-09-12 2022-12-08 169133
INHIBACE 5MG TABLET Resolved 2020-05-13 2021-10-19 114894
INHIBACE 2.5MG TABLET Actual shortage 2018-11-26 2019-02-19 67581
RIVOTRIL 0.5MG TABLET Resolved 2017-11-07 2017-12-13 28573
RIVOTRIL 0.5MG TABLET Resolved 2018-01-03 2018-04-21 34871
RIVOTRIL 0.5MG TABLET Resolved 2022-10-12 2023-04-01 171577
RIVOTRIL 2MG TABLET Resolved 2022-10-12 2023-04-01 171580
ANANDRON 50MG TABLET Resolved 2017-06-21 2017-07-06 13478
ANANDRON 50MG TABLET Resolved 2019-11-21 2019-12-16 99378
ANANDRON 50MG TABLET Resolved 2021-03-08 2021-06-16 135253
INHIBACE PLUS 5MG 12.5MG TABLET Resolved 2021-01-04 2021-10-19 130792
INHIBACE PLUS 12.5MG 5MG TABLET Resolved 2022-05-09 2022-05-25 160204
INHIBACE PLUS 12.5MG 5MG TABLET Resolved 2022-08-17 2022-09-30 166884
VALCYTE 450MG TABLET Resolved 2023-05-02 2023-05-25 191490

Showing 21 to 38 of 38

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
SUPREFACT 100MCG SOLUTION Discontinued 2021-12-13 2021-12-13 151039
XELODA 150MG TABLET Discontinued 2022-11-30 2022-12-01 176355
XELODA 500MG TABLET Discontinued 2022-11-30 2022-12-01 176359
LOSEC 20MG TABLET (DELAYED-RELEASE) Discontinued 2021-11-19 2021-11-19 149669

Showing 1 to 4 of 4